Neurocognitive moderation of associations between cannabis use and psychoneuroticism

Journal of Clinical and Experimental Neuropsychology

Volumn 36, Issue 8, 2014, Pages 794-805

  Huijbregts, Stephan C J ^a,b   Griffith Lendering, Merel F H ^a   Vollebergh, Wilma A M ^c   Swaab, Hanna ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cannabis; Cognitive ability; Emotion recognition; Psychoneuroticism; Social perception

Indexed keywords

ADULT; ATTENTION; CANNABIS ADDICTION; COGNITION DISORDERS; COMPLICATION; EMOTION; FACE; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NEUROSIS; PATTERN RECOGNITION; PHOTOSTIMULATION; PSYCHOLOGICAL RATING SCALE; SELF REPORT; YOUNG ADULT;

ADULT; ATTENTION; COGNITION DISORDERS; EMOTIONS; FACE; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; NEUROPSYCHOLOGICAL TESTS; NEUROTIC DISORDERS; PATTERN RECOGNITION, VISUAL; PHOTIC STIMULATION; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; YOUNG ADULT;

EID: 84922020096     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2014.943694     Document Type: Article

References (71)

1. Adolphs, R. (2002). Recognizing emotion from facial expressions: Psychological and neurological mechanisms. Behavioral and Cognitive Neuroscience Reviews, 1, 21-62.
2. Arrindell, W. A., & Ettema, J. H. M. (1986). The SCL-90: A multidimensional instrument for the assessment of psychopathology. Lisse: Swets & Zeitlinger.
3. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal, 325, 1212-1213.
4. Becker, M. P., Collins, P. F., & Luciana, M. (2014). Neurocognition in college-aged daily marijuana users. Journal of Clinical and Experimental Neuropsychology, 36, 379-398. doi:10.1080/13803395.2014.893996
5. Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014). Acute and non-acute effects of cannabis on human memory function: A critical review of neuroimaging studies. Current Pharmaceutical Design, 20, 2114-2125.
6. Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011). Cannabis use in young people: The risk for schizophrenia. Neuroscience and Biobehavioral Reviews, 35, 1779-1787.
7. Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Craig, I. W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene × environment interaction. Biological Psychiatry, 57, 1117-1127.
8. Clark, P. A., Capuzzi, K., & Fick, C. (2011). Medical marijuana: Medical necessity versus political agenda. Medical Science Monitor, 17, RA249-RA261.
9. Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of Addiction Medicine, 5, 1-8.
10. Creemers, H. E., Dijkstra, J. K., Vollebergh, W. A. M., Ormel, J., Verhulst, F. C, & Huizink, A. C. (2010). Predicting life-time and regular cannabis use during adolescence; the roles of temperament and peer substance use: The TRAILS study. Addiction, 105, 699-708.
11. Degenhardt, L., Hall, W., & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37-48.
12. Demenescu, L. R., Kortekaas, R., Den Boer, J. A., & Aleman, A. (2010). Impaired attribution of emotion to facial expressions in anxiety and major depression. PLoS One, 5, e15058.
13. Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale-Preliminary report. Psychopharmacological Bulletin, 9, 13-28.
14. De Sonneville, L. M. J. (1999). Amsterdam neuropsychological tasks: A computer-aided assessment program. In B. P. L. M. den Brinker, A. N. Brand, F. J. Maarse, & L. J. M. Mulder (Eds.), Cognitive ergonomics, clinical assessment and computer-assisted learning: Computers in psychology (pp. 87-203). Lisse: Swets and Zeitlinger.
15. De Sonneville, L. M. J., Verschoor, C. A., Njiokiktjien, C, Op het Veld, V., Toorenaar, N., & Vranken, M. (2002). Facial identity and facial emotions: Speed, accuracy, and processing strategies in children and adults. Journal of Clinical and Experimental Neuropsychology, 24, 200-213.
16. D'Souza, D. C, Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y. T., Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahy-drocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29, 1558-1572.
17. Elliott, R., Fox, C. M., Beltyukova, S. A., Stone, G. E., Gunderson, J., & Zhang, X. (2006). Deconstructing therapy outcome measurement with Rasch analysis of a measure of general clinical distress: The Symptom Checklist-90-Revised. Psychological Assessment, 18, 359-372.
18. European Monitoring Centre for Drugs and Drug Addiction. (2009). The state of the drugs problem in Europe: Annual report. Retrieved from http://www.emcdda.europa.eu/publications/annual-report/2009
19. Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2007). Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: Results of a 25-year longitudinal study. Drug and Alcohol Dependence, 88, 14-26.
20. Fridberg, D. J., Vollmer, J. M, O'Donnell, B. F., & Skosnik, P. D. (2011). Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Research, 30, 46-52.
21. Germine, L. T., & Hooker, C. I. (2011). Face emotion recognition is related to individual differences in psychosis-proneness. Psychological Medicine, 41, 937-947.
22. Glass, M., Dragunow, M., & Faull, R. L. (1997). Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult brain. Neuroscience, 77, 299-318.
23. Grant, I., Hampton Atkinson, J., Gouaux, B., & Wilsey, B. (2012). Medical marijuana: Clearing away the smoke. The Open Neurology Journal, 6, 18-25.
24. Griffith-Lendering, M. F. H, Huijbregts, S. C. J., Mooijaart, A., Vollebergh, W. A. M., & Swaab, H. (2011). Cannabis use and development of externalizing and internalizing behavior problems in early adolescence: A TRAILS-study. Drug and Alcohol Dependence, 116, 11-17.
25. Griffith-Lendering, M. F. H, Huijbregts, S. C. J., Vollebergh, W. A. M., & Swaab, H. (2012). Motivational and cognitive inhibitory control in recreational cannabis users. Journal of Clinical and Experimental Neuropsychology, 34, 688-697.
26. Griffith-Lendering, M. F. H., Wigman, J. T. W., Prince van Leeuwen, A., Huijbregts, S. C. J., Huizink, A. C, Ormel, J., Vollebergh, W. A. M., (2013). Cannabis use and vulnerability for psychosis in early adolescence: A TRAILS Study. Addiction, 108, 733-740.
27. Gruber, S. A., Rogowska, J., & Yurgelun-Todd, D. A. (2009). Altered affective response in marijuana smokers: An fMRI study. Drug and Alcohol Dependence, 105, 139-153.
28. Hasin, D. S., O'Brien, C. P., Auriacombe, M., Borges, G, Bucholz, K., Budney, A., Grant, B. F. (2013). DSM-5 criteria for substance use disorders: Recommendations and rationale. American Journal of Psychiatry, 170, 834-851.
29. Hayatbakhsh, M. R., Najman, J. M., Jamrozik, K., Mamun, A. A., Alati, R., & Bor, W. (2007). Cannabis and anxiety and depression in young adults: A large prospective study. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 408-417.
30. Henquet, C, Di Forti, M., Morrison, P., Kuepper, R., & Murray, R. M. (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin, 34, 1111-1121.
31. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990). Cannabinoid receptor localization in the brain. Proceedings of the National Academy of Sciences of the United States of America, 87, 1932-1936.
32. Huijbregts, S. C. J., De Sonneville, L. M. J., Licht, R., Van Spronsen, F. J., Verkerk, P. H, & Sergeant, J. A. (2002). Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia, 40, 7-15.
33. Huijbregts, S., Jahja, R., De Sonneville, L., De Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis Type 1. Developmental Medicine and Child Neurology, 52, 620-625.
34. Huizink, A. C, Ferdinand, R. F., Ormel, J., & Verhulst, F. C. (2006). Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction, 101, 1581-1588.
35. Jaddoe, V. W., Mackenbach, J. P., Moll, H. A., Steegers, E. A., Tiemeier, H., Verhulst, F. C, Hofman, A. (2006). The Generation R Study: Design and cohort profile. European Journal of Epidemiology, 21, 475-484.
36. Kelleher, L. M., Stough, C, Sergejew, A. A., & Rolfe, T. (2004). The effects of cannabis on information-processing speed. Addictive Behaviors, 29, 1213-1219.
37. Kleber, H. D., & DuPont, R. L. (2012). Physicians and medical marijuana. American Journal of Psychiatry, 169, 564-568.
38. Lynskey, M. T., Vink, J. M., & Boomsma, D. I. (2006). Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behavior Genetics, 36, 195-200.
39. Macare, C, Bates, T. C, Heath, A. C, Martin, N. G., & Ettinger, U. (2012). Substantial genetic overlap between schizotypy and neuroticism. Behavior Genetics, 42, 732-742.
40. Marsh, A. A., & Blair, R. J. (2008). Deficits in facial affect recognition among antisocial populations: A meta-analysis. Neuroscience and Biobehavioral Reviews, 32, 454-465.
41. McQueeny, T., Padula, C. B., Price, J, Lisdahl Medina, K, Logan, P., & Tapert, S. F. (2011). Gender effects on amygdala morphometry in adolescent marijuana users. Behavioural Brain Research, 224, 128-134.
42. Monshouwer, K., Van Dorsselaer, S., Verdurmen, J., Ter Bogt, T., De Graaf, R., & Vollebergh, W. (2006). Cannabis use and mental health in secondary school children. Findings from a Dutch survey. British Journal of Psychiatry, 188, 148-153.
43. Moore, T. H. M., Zammit, S., Ligford-Hughes, A., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370, 319-328.
44. Morgan, C. J. A., Duffin, S., Hunt, L., Monaghan, L., Mason, O., & Curran, H. V. (2012). Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ("skunk") or on cocaine. Pharmacopsychiatry, 45, 269-274.
45. Morrison, P. D., & Murray, R. M. (2009). From real-world events to psychosis: The emerging neuropharmacology of delusions. Schizophrenia Bulletin, 35, 668-674.
46. Nisbett, R. E., Aronson, J., Blair, C, Dickens, E., Flynn, J., Halpern, D. F., & Turkheimer, E. (2012). Intelligence: New findings and theoretical developments. The American Psychologist, 67, 130-159.
47. Nordstrom, B. R., & Hart, C. L. (2006). Assessing cognitive functioning in cannabis users: Cannabis use history an important consideration. Neuropsychopharmacology, 31, 2798-2799.
48. Ochsner, K. M. (2008). The social-emotional processing stream: Five core constructs and their translational potential for schizophrenia and beyond. Biological Psychiatry, 64, 48-61.
49. Olsen, L. R., Mortensen, E. L., & Bech, P. (2004). The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatrica Scandinavica, 110, 330-350.
50. O'Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. Substance Use and Misuse, 18, 805-824.
51. Otten, R., Barker, E. D., Maughan, B., Arseneault, L., & Engels, R. C. M. E. (2010). Self-control and its relation to joint developmental trajectories of cannabis use and depressive mood symptoms. Drug and Alcohol Dependence, 112, 201-208.
52. Phan, K. L., Angstadt, M., Golden, J., Onyewuenyi, I., Popovska, A., & De Wit, H. (2008). Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. Journal of Neuroscience, 28, 2313-2319.
53. Platt, B., Kamboj, S., Morgan, C. J., Curran, H. V. (2010). Processing dynamic facial affect in frequent cannabis-users: Evidence of deficits in the speed of identifying emotional expressions. Drug and Alcohol Dependence, 112, 27-32.
54. Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58, 909-915.
55. Prince van Leeuwen A., Creemers, H. E., Greaves-Lord, K. Verhulst, F. C, Ormel, J., & Huizink, A. C. (2011). Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: The TRAILS study. Addiction, 106, 1484-1492.
56. Rey, J. M., Sawyer, M. G., Raphael, B., Patton, G. C, & Lynskey, M. (2002). Mental health of teenagers who use cannabis-Results of an Australian survey. British Journal of Psychiatry, 180, 216-221.
57. Rössler, W., Vetter, S., Müller, M., Gallo, W. T., Haker, H., Kawohl, W., Ajdacic-Gross, V. (2011). Risk factors at the low end of the psychosis continuum: Much the same as at the upper end? Psychiatry Research, 189, 77-81.
58. Schubart, C. D., Van Gastel, W. A., Breetvelt, E. J., Beetz, S. L., Ophoff, R. A., Sommer, I. E., Boks, M. P. (2011). Cannabis use at a young age is associated with psychotic experiences. Psychological Medicine, 41, 1301-1310.
59. Sobell, L. C, & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. In R. Z. Litten & J. P. Allen (Eds.), Measuring alcohol consumption: Psychosocial and biochemical methods (pp. 41-72). Totowa, NJ: Humana Press.
60. Solowij, N., & Battisti, R. (2008). The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews, 1, 81-98.
61. Stacy, A. W., & Wiers, R. W. (2010). Implicit cognition and addiction: A tool for explaining paradoxical behavior. Annual Review of Clinical Psychology, 6, 551-575.
62. Substance Abuse and Mental Health Services Administration. (2008). Results from the 2007 National Survey on Drug Use and Health: National findings. Rockville, MD: Author.
63. Swift, W., Coffey, C, Degenhardt, L., Carlin, J. B., Romaniuk, H., & Patton, G. C. (2012). Cannabis and progression to other substance use in young adults: Findings from a 13-year prospective population-based study. Journal of Epidemiology and Community Health, 66, e26.
64. Tait, R. J., MacKinnon, A., & Christensen, H. (2011). Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction, 106, 2195-2203.
65. Tan, H., Lauzon, N. M., Bishop, S. F., Bechard, M. A., & Laviolette, S. R. (2010). Integrated cannabinoid CB1 receptor transmission within the amygdala-prefrontal cortical pathway modulates neuronal plasticity and emotional memory encoding. Cerebral Cortex, 20, 1486-1496.
66. Van Nierop, M., Van Os, J., Gunther, N., Myin-Germeys, I., De Graaf, R., Ten Have, M., Van Winkel, R. (2012). Phenotypically continuous with clinical psychosis, discontinuous in need for care: Evidence for an extended psychosis phenotype. Schizophrenia Bulletin, 38, 231-238.
67. Verdejo-Garcia, A., Lawrence, A. J., & Clark, L. (2008). Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews, 32, 777-810.
68. Wadsworth, E. J., Moss, S. C., Simpson, S. A., & Smith, A. P. (2006). Cannabis use, cognitive performance and mood in a sample of workers. Journal of Psychopharmacology, 20, 14-23.
69. Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: Results of a nationwide survey. International Journal of Clinical Practice, 59, 291-295.
70. Yacubian, J., & Büchel, C. (2009). The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. Neuroscience, 164, 55-71.
71. Yucel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I. (2008). Regional brain abnormalities associated with longterm heavy cannabis use. Archives of General Psychiatry, 65, 694-701.